Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT05729048
Other study ID # BXU578332
Secondary ID
Status Withdrawn
Phase
First received
Last updated
Start date July 15, 2023
Est. completion date March 14, 2025

Study information

Verified date July 2023
Source Baxter Healthcare Corporation
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Hemodynamic optimization of critically ill patients is a goal for clinicians in order to afford the patient the best possible outcomes. Being able to precisely and rapidly determine patient fluid responsiveness provides the bedside physician and nursing staff the information needed to make critical decisions in regard to the patient's fluid status and management of additional fluids and medications. As fluid management and cardiac output determination are linked to better decision-making and improved outcomes in ICU, the use of a dynamic assessment of fluid responsiveness becomes a key tool for patient management. This study is designed to collect treatment and outcome data on patients that have undergone hemodynamic monitoring during CRRT therapy.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date March 14, 2025
Est. primary completion date March 14, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 95 Years
Eligibility Inclusion Criteria: 1. =18 to 95 years of age. 2. Patient has undergone hemodynamic monitoring with the Starling monitor during a CRRT treatment. 3. Hemodynamic monitoring was completed no earlier than 2018 Exclusion Criteria: 1. Patients did not have an arterial line in place during CRRT treatment 2. Patients on extracorporeal membrane oxygenation (ECMO) or left ventricular assist device (LVAD) 3. Patients with end-stage kidney disease on chronic dialysis 4. Hemodynamic monitoring with Starling did not occur during CRRT treatment 5. Data from Starling, CRRT machine, or arterial line cannot be retrieved

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Starling
Starling is a portable, non-invasive, cardiac output detector system. The Starling monitor measures the cardiac output by employing electrical bioreactance. Bioreactance is a measure of the electrical characteristics of a volume of tissue and fluid. In the case of cardiac output measurements, the relevant tissue includes the heart and the immediate surrounding volume of the thorax. The relevant fluid is blood. The Starling electrode is a double electrode sensor. Within each sensor, one electrode is used to transmit a high frequency sine wave into the body, while the resulting voltage is measured at the adjacent electrode. This information is used to determine cardiac output. The Starling monitor also measures and displays associated hemodynamic parameters based on calculations of measurements already incorporated into the Starling monitor.

Locations

Country Name City State
United States Baxter Investigational Site Lexington Kentucky

Sponsors (1)

Lead Sponsor Collaborator
Baxter Healthcare Corporation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in stroke volume (SV) after CRRT initiation Day 1 (during CRRT)
Primary Change in cardiac output (CO) after fluid removal Cardiac physiology adjusted to net ultrafiltration intensities (ml/kg/h) Day 1 (during CRRT)
Primary Change in cardiac index (CI) after fluid removal Cardiac physiology adjusted to net ultrafiltration intensities (ml/kg/h) Day 1 (during CRRT)
Primary Change in stroke volume (SV) after fluid removal Cardiac physiology adjusted to net ultrafiltration intensities (ml/kg/h) Day 1 (during CRRT)
Primary Change in stroke volume index (SVI) after fluid removal Cardiac physiology adjusted to net ultrafiltration intensities (ml/kg/h) Day 1 (during CRRT)
Primary Change in Thoracic Fluid Content (TFC) after fluid removal Cardiac physiology adjusted to net ultrafiltration intensities (ml/kg/h) Day 1 (during CRRT)
Primary Change in heart rate (HR) after fluid removal Cardiac physiology adjusted to net ultrafiltration intensities (ml/kg/h) Day 1 (during CRRT)
Primary Change in systolic blood pressure (SBP) after fluid removal Cardiac physiology adjusted to net ultrafiltration intensities (ml/kg/h) Day 1 (during CRRT)
Primary Change in diastolic blood pressure (DBP) after fluid removal Cardiac physiology adjusted to net ultrafiltration intensities (ml/kg/h) Day 1 (during CRRT)
Primary Change in central venous pressure (CVP) after fluid removal Cardiac physiology adjusted to net ultrafiltration intensities (ml/kg/h) Day 1 (during CRRT)
Primary Change in mixed venous oxygen saturation (SVO2) after fluid removal Perfusion parameter adjusted to net ultrafiltration intensities (ml/kg/h) Day 1 (during CRRT)
Primary Change in lactate after fluid removal Perfusion parameter adjusted to net ultrafiltration intensities (ml/kg/h) Day 1 (during CRRT)
Primary Changes in systolic blood pressure (SBP) from beginning to end of CRRT Day 1 (Begin CRRT) through Day 1 (End of CRRT)
Primary Changes in diastolic blood pressure (DBP) from beginning to end of CRRT Day 1 (Begin CRRT) through Day 1 (End of CRRT)
Primary Changes in mean arterial pressure (MAP) from beginning to end of CRRT Day 1 (Begin CRRT) through Day 1 (End of CRRT)
Secondary Incidence of intradialytic hypotension (IDH) during CRRT Day 1 (during CRRT)
Secondary Incidence of intradialytic hypotension (IDH) free time during CRRT Day 1 (during CRRT)
Secondary Incidence of time to resolution in intradialytic hypotension (IDH) during CRRT Day 1 (during CRRT)
Secondary Changes in intake and output (I/O) during CRRT Fluid balance parameter Day 1 (during CRRT)
Secondary Changes in hourly/daily fluid balance during CRRT Day 1 (during CRRT)
Secondary Changes in cumulative fluid balance during CRRT Day 1 (during CRRT)
Secondary Changes in percent fluid overload during CRRT Fluid balance parameter Day 1 (during CRRT)
Secondary Changes in ultrafiltration parameters and net ultrafiltration (UFnet) during CRRT Day 1 (during CRRT)
Secondary Incidence of ultrafiltration failure during CRRT Including prescribed/archived, time to fluid balance Day 1 (during CRRT)
Secondary Blood flow rate during CRRT Day 1 (during CRRT)
Secondary CRRT dose/modality Day 1 (during CRRT)
Secondary Estimate the contribution degree of certain patient conditions, clinical characteristics, fluid, and CRRT parameters in predicting the IDH risk during CRRT Day 1 (during CRRT)
Secondary Identify sub-phenotypes of patients at risk of IDH during CRRT Day 1 (during CRRT)
See also
  Status Clinical Trial Phase
Completed NCT04972266 - The EU Hyprotect Registry
Not yet recruiting NCT03691103 - Record and Analyze the Data of Patient Undergoing Anesthesia for Laparoscopic Cholecystectomy From Patient Monitoring Instruments
Active, not recruiting NCT04281771 - Assessment of Paravalvular Leak After TAVI by Hemodynamic Measurements and Cardiac MRI N/A
Recruiting NCT05543824 - Hemodynamic Impact of Epidural Anesthesia in Relation to Age in Pediatric Patients.
Terminated NCT03208023 - RESIPI for Reducing Perioperative Major Adverse Cardiac Events N/A
Not yet recruiting NCT00966147 - Advanced Hemodynamic Monitoring for Goal-directed Hemodynamic Management During Radical Cystectomy N/A
Recruiting NCT05445037 - Hemodynamic and Cerebral Effects Evaluation in Anesthesia N/A
Completed NCT04517409 - Goal-directed Hemodynamic Therapy in Patiens Undergoing Major Hepatic Resection N/A
Terminated NCT02950649 - Evaluation of Clinical Impact of Non-Invasive Hemodynamic Monitoring to Optimize Perioperative Care
Completed NCT04648293 - Starling Registry Study
Completed NCT04535115 - Tidal Volume Challenge and Lung Recruitment Maneuver (TIDALREC): the Reliability of Pulse Pression Variation or Stroke Volume Variation on Fluid Responsiveness. N/A
Recruiting NCT05418881 - Evaluation and Implementation of Mobile Tracking Devices to Increase Safety in Hospitalized Patients (MONITOR) N/A
Completed NCT05779683 - Caretaker in the Cardiovascular Intensive Care Unit (CVICU)
Terminated NCT04996420 - Goal Directed Fluid Therapy Versus Liberal Fluid Regimen in Primary Elective Hip Artrhoplasty N/A
Recruiting NCT02156856 - Stroke Volume Analysis During Aortic Valve Replacement Trial N/A
Completed NCT00624494 - Single Transpulmonary Thermodilution and Continuous Monitoring of Central Venous Oxygen Saturation During Off-pump Coronary Surgery N/A
Recruiting NCT04109339 - Effects of Oxytocin on Hemodynamics in Patients Undergoing Laparoscopic Myomectomy N/A
Completed NCT04241926 - Single-lumen 5Fr and Triple-lumen 6Fr PICCs Are Accurate for Hemodynamic Measurement by Transpulmonary Thermodilution. N/A
Completed NCT05365113 - Comparison of Hemodynamic Effects of Two Modalities of Alveolar Recruitment Maneuvers in Major Abdominal Surgery Patients N/A
Completed NCT03893513 - Comparison of Transthoracic Electrical Bioimpedance and Pulse Contour Analysis in Renal Transplantation Patients